Clinical Trial Update: Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for RM-1929 photoimmunotherapy in recurrent head and neck cancer has completed Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• RM-1929

Snippet

Sponsor: Rakuten Medical, Inc. | Conditions: Recurrent Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED